RANO criteria for brain metastases (RANO-BM) - Radiopaedia.org
2021年7月13日 · Response assessment in neuro-oncology brain metastases (RANO-BM) criteria are recommendations for standardized tumor response and progression assessment in clinical trials involving brain metastases. Published in 2015, these should not be confused with the RANO criteria for high-grade glioma from the same group.
The Response Assessment in Neuro-Oncology Brain Metastases (RANO-BM) working group is an international, multidisciplinary eff ort to develop standard response and progression criteria for use in clinical trials of treatment for brain metastases.
RECIST 1.1 mainly referred as assessment criteria in oncology clinical trials, present apparent drawbacks addressed by RANO-BM proposed in 2015. The fundamental of RANO-BM is the separately identified target, non-target, and post-baseline new lesions from intracranial and extracranial lesions.
RANO 2.0 脑胶质瘤治疗反应评估新标准 - 脑医汇 - 神外资讯 - 神 …
为了提高临床试验中治疗反应评估的可靠性和可比性，并辅助确定更有效的治疗方法，rano工作组于2010年发布了高级别胶质瘤的反应评价标准（rano-hgg），2011年发布了低级别胶质瘤的反应评价标准（rano-lgg）。
Response assessment criteria for brain metastases: proposal from …
The Response Assessment in Neuro-Oncology Brain Metastases (RANO-BM) working group is an international, multidisciplinary effort to develop standard response and progression criteria for use in clinical trials of treatment for brain metastases.
O7.01: RESPONSE ASSESSMENT IN NEURO-ONCOLOGY (RANO) …
An international multidisciplinary group, The Response Assessment in Neuro-Oncology (RANO) Metastatic Working Group has proposed a RANO-Brain Metastases (RANO-BM) Criteria is based on a modification of RECIST 1.1 criteria and uses unidimensional measurements.
Use of the Response Assessment in Neuro-Oncology (RANO) …
In aiming to standardize and improve clinical trials in which systemic agents are investigated in patients with BM, the RANO-BM offers the following: strategies to determine potential CNS activity of the drug in question, understanding the potential disease response both intra- and extracranially, the potential for prevention of BM in high-risk ...
【综述】脑转移瘤:临床影像学的作用 - 脑医汇 - 神外资讯 - 神介资讯
对于脑转移瘤，RANO小组提出了评估(RANO- BM标准)和ICI治疗后随访(iRANO标准)的建议。根据RANO-BM标准，最多5个脑转移瘤的直径是单径线测量和其总和（unidimensionally measured and summed）。进展的定义是与基线MRI或显示最佳反应的MRI相比，这个总和有超过20%的增长。
【文献快递】用RANO-BM标准评价脑转移瘤患者放射外科治疗靶 …
《用rano - bm标准评价脑转移瘤患者放射外科治疗靶区和非靶区病变的效果》一文，对66例患者分组研究。 阐述了放射外科治疗指征扩大背景下，用RANO - BM标准评估治疗效果的情况。
[研究]脑胶质瘤假性进展与治疗效果如何判断: RANO标准—高级别 …
2017年10月16日 · RANO标准经过近6年的临床实践，得到了神经肿瘤学界的认可，也成为高级别胶质瘤临床试验研究的常用评价标准。 高级别胶质瘤的治疗反应评价标准. 本文作者：首都医科大学附属北京世纪坛医院脑胶质瘤科李文斌 康勋 张红梅 陈建新；哈佛医学院神经肿瘤中心医学肿瘤系Wen Patrick Y ；首都医科大学附属北京天坛医院神经外科江涛；本文发表于中华神经外科杂志2017年3月第33卷第3期；转载自医脉通网站. 胶质瘤是最常见的颅内原发肿瘤，年发病率约 …